Literature DB >> 21286263

Increasing Access to Cognitive-Behavioural Therapy (CBT) for the Treatment of Mental Illness in Canada: A Research Framework and Call for Action.

Krista A Payne1, Gail Myhr.   

Abstract

International studies suggest that cognitive-behavioural therapy (CBT) for the treatment of mental disorders results in improved clinical and economic outcomes. In Canada, however, publicly funded CBT is scarce, representing an inequity in service delivery. A research framework to evaluate the Canadian health economic impact of increasing access to CBT is proposed. Canadian data related to the epidemiology of mental disorders, patterns of usual care, CBT effectiveness, resource allocation and costs of care will be required and methodologies should be transparent and outcomes meaningful to Canadian decision-makers. Findings should be delivered by multidisciplinary teams of researchers and health professionals. Barriers to funding reform must be identified and knowledge translation strategies delineated and implemented. Canadian clinical and economic outcomes data are essential for those seeking to provide decision-makers with the evidence they need to evaluate whether CBT represents value for mental health dollars spent.

Entities:  

Year:  2010        PMID: 21286263      PMCID: PMC2831741     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


  39 in total

1.  Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'?

Authors:  T Duthie; P Trueman; J Chancellor; L Diez
Journal:  Health Policy       Date:  1999-01       Impact factor: 2.980

2.  The Canadian Community Health Survey: mental health and well-being.

Authors:  Ronald Gravel; Yves Béland
Journal:  Can J Psychiatry       Date:  2005-09       Impact factor: 4.356

Review 3.  The case for psychological treatment centres.

Authors:  Richard Layard
Journal:  BMJ       Date:  2006-04-29

4.  Psychological treatment centres: may be less effective than suggested.

Authors:  Martin Zinkler
Journal:  BMJ       Date:  2006-05-13

5.  Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysis.

Authors:  Pasquale Roberge; André Marchand; Daniel Reinharz; Pierre Savard
Journal:  Behav Modif       Date:  2008-05

6.  Cost-effectiveness of an intervention to prevent depression in at-risk teens.

Authors:  Frances L Lynch; Mark Hornbrook; Gregory N Clarke; Nancy Perrin; Michael R Polen; Elizabeth O'Connor; John Dickerson
Journal:  Arch Gen Psychiatry       Date:  2005-11

7.  Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study.

Authors:  Dominic H Lam; Paul McCrone; Kim Wright; Natalie Kerr
Journal:  Br J Psychiatry       Date:  2005-06       Impact factor: 9.319

Review 8.  Developing guidance for budget impact analysis.

Authors:  P Trueman; M Drummond; J Hutton
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 9.  Economic evaluation of mental health care interventions. A review.

Authors:  S M Evers; A S Van Wijk; A J Ament
Journal:  Health Econ       Date:  1997 Mar-Apr       Impact factor: 3.046

10.  Empirically supported treatments for panic disorder: costs, benefits, and stepped care.

Authors:  M W Otto; M H Pollack; K M Maki
Journal:  J Consult Clin Psychol       Date:  2000-08
View more
  10 in total

1.  A feasibility study of a telephone-supported self-care intervention for depression among adults with a comorbid chronic physical illness in primary care.

Authors:  Jane McCusker; Martin Cole; Mark Yaffe; Tamara Sussman; Kim L Lavoie; Erin Strumpf; Maida Sewitch; Deniz Sahin; Manon de Raad
Journal:  Ment Health Fam Med       Date:  2012-12

2.  We need psychologists!

Authors:  Meta van den Heuvel; Tony Barozzino; Karen Milligan; Elizabeth Ford-Jones; Sloane Freeman
Journal:  Paediatr Child Health       Date:  2016 Jan-Feb       Impact factor: 2.253

3.  Current and emerging directions in the treatment of eating disorders.

Authors:  Tiffany A Brown; Pamela K Keel
Journal:  Subst Abuse       Date:  2012-03-29

Review 4.  Understanding the Impact of Brain Disorders: Towards a 'Horizontal Epidemiology' of Psychosocial Difficulties and Their Determinants.

Authors:  Alarcos Cieza; Marta Anczewska; Jose Luis Ayuso-Mateos; Mary Baker; Jerome Bickenbach; Somnath Chatterji; Sally Hartley; Matilde Leonardi; Tuuli Pitkänen
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

5.  Supporting Homework Compliance in Cognitive Behavioural Therapy: Essential Features of Mobile Apps.

Authors:  Wei Tang; David Kreindler
Journal:  JMIR Ment Health       Date:  2017-06-08

6.  Mamma Mia - A randomized controlled trial of an internet-based intervention for perinatal depression.

Authors:  Silje Marie Haga; Filip Drozd; Carina Lisøy; Tore Wentzel-Larsen; Kari Slinning
Journal:  Psychol Med       Date:  2018-09-07       Impact factor: 7.723

7.  Examining the Impact of Digital Components Across Different Phases of Treatment in a Blended Care Cognitive Behavioral Therapy Intervention for Depression and Anxiety: Pragmatic Retrospective Study.

Authors:  Monica S Wu; Robert E Wickham; Shih-Yin Chen; Connie Chen; Anita Lungu
Journal:  JMIR Form Res       Date:  2021-12-17

Review 8.  Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-11-13

9.  Netmums: a phase II randomized controlled trial of a guided Internet behavioural activation treatment for postpartum depression.

Authors:  H A O'Mahen; D A Richards; J Woodford; E Wilkinson; J McGinley; R S Taylor; F C Warren
Journal:  Psychol Med       Date:  2013-10-23       Impact factor: 7.723

10.  An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes.

Authors:  Vishal K Thakur; Jacquelyne Y Wong; Jason R Randall; James M Bolton; Sagar V Parikh; Natalie Mota; Debbie Whitney; Joshua Palay; Jolene Kinley; Simran Diocee; Tanya Sala; Jitender Sareen
Journal:  BMC Psychiatry       Date:  2019-05-03       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.